MQX-503, a novel topical nitroglycerin formulation, improves severity of symptoms associated with Raynaud's phenomenon

Jill Belch, David Fiorentino, Cluistopher Denton, Ariane Herrick, Sangeeta Sule, Virginia Steen, Naomi Rothfield, Agneta Scheja, Lee Shapiro, Joseph Shanahan, Paul Emery, Lorinda Chung, Jeffrey K. Gregory

Research output: Contribution to journalPublished meeting abstractpeer-review

Original languageEnglish
Pages (from-to)S622-S622
JournalArthritis and Rheumatism
Volume58
Issue number9
Publication statusPublished - 2008
Event72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals - San Francisco, CA
Duration: 2008 Oct 242008 Oct 29

Subject classification (UKÄ)

  • Clinical Medicine

Cite this